Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Compare cardiac index by right ventricular waveform vs. thermodilution in septic shock patients

Official title: Comparison of Cardiac Index Measurement by Analysis of the Right Ventricular Pressure Curve and by Thermodilution During Pulmonary Artery Catheterization Using Swan Ganz IQ™.

Run by Assistance Publique - Hôpitaux de Paris · NCT07628023 · Data updated 2026-11-12

This study tests whether the continuous cardiac index estimated from the right ventricular pressure waveform matches the thermodilution measurement in adults with septic shock who already have a Swan-Ganz catheter in place.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment43 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations2 sites (Angers and 1 other locations)
StatusRecruiting
StartedOctober 15, 2026
Main results expectedOctober 16, 2028
Study endsOctober 16, 2028
Registry record updatedOctober 27, 2026
Trial IDNCT07628023 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) in the ICU who have a Swan-Ganz IQ catheter placed as part of their care and have undergone thermodilution measurements.

Probably not a fit

Patients with conditions that disrupt right heart waveform analysis or with unreliable catheter data may not benefit from the continuous estimate.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes data from ICU patients with septic shock who have a Swan-Ganz IQ catheter. It compares the traditional thermodilution cardiac index with a continuous estimate derived from the right ventricular pressure waveform. The goal is to see how closely the continuous method agrees with the gold-standard thermodilution in real clinical settings, including during volume expansion tests. The study plans to assess concordance across different clinical situations that may affect right heart function, such as right ventricular dysfunction or valvular disease. Findings could influence how clinicians monitor cardiac output in the ICU when rapid, ongoing estimates are desirable.

Why it matters

Potential benefit: If the continuous method aligns well with thermodilution, clinicians could monitor cardiac index more rapidly and conveniently without repeated injections.

How similar studies have gone: Prior work suggests variable agreement between continuous waveform-based estimates and thermodilution, making independent clinical data valuable for validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Hospitalization in intensive care
* Presence of a Swan-Ganz IQ™ pulmonary artery catheter placed as part of treatment
* Thermodilution performed by the clinician in charge as part of treatment

Exclusion Criteria:

* Pregnancy
* Legal protective measures (guardianship, conservatorship, and deprivation of liberty by court/administrative decision)
* Refusal of participation by the patient's relatives or the patient themselves.
* Cardiac output measurements by thermodilution or continuous cardiac output analysis that cannot be used.

Where it's running

  • Pierre ASFAR
    Angers, France
    Recruiting
  • Xavier MONNET
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.